A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient

SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (ICC) has limited prognosis and therapies. The first-line gemcitabine-based therapy provided poor benefits in terms of survival due to the development of resistance. Gemcitabine-resistance mechanisms were studied on pancreatic cancer models or cell lin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Peraldo-Neia, Caterina, Massa, Annamaria, Vita, Francesca, Basiricò, Marco, Raggi, Chiara, Bernabei, Paola, Ostano, Paola, Casorzo, Laura, Panero, Mara, Leone, Francesco, Cavalloni, Giuliana, Aglietta, Massimo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8123022/
https://ncbi.nlm.nih.gov/pubmed/33922695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13092051
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia